|
Name |
3-Decen-2-one
|
Molecular Formula | C10H18O | |
IUPAC Name* |
(E)-dec-3-en-2-one
|
|
SMILES |
CCCCCC/C=C/C(=O)C
|
|
InChI |
InChI=1S/C10H18O/c1-3-4-5-6-7-8-9-10(2)11/h8-9H,3-7H2,1-2H3/b9-8+
|
|
InChIKey |
JRPDANVNRUIUAB-CMDGGOBGSA-N
|
|
Synonyms |
3-Decen-2-one; 10519-33-2; dec-3-en-2-one; Heptylidene acetone; (E)-dec-3-en-2-one; Oenanthylidene acetone; Trans-3-decen-2-one; (E)-3-Decen-2-one; 18402-84-1; (3E)-Dec-3-en-2-one; 3-Decen-2-one, (E)-; FEMA No. 3532; 3-Decen-2-one, (3E)-; Z22804BQXD; EINECS 234-059-0; Enanthylidene acetone; (3E)-3-Decen-2-one; UNII-Z22804BQXD; trans-Decen-2-al; SCHEMBL120780; CHEMBL206566; 3-DECEN-2-ONE [FHFI]; DTXSID201315551; ZINC1850723; MFCD00015700; (3E)-3-DECEN-2-ONE [MI]; AS-40174; CS-0440272; D1933; A905941; Q27294888; 3-Decen-2-one, predominantly trans, >=97%, stabilized, FG
|
|
CAS | 18402-84-1 | |
PubChem CID | 5363233 | |
ChEMBL ID | CHEMBL206566 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 154.25 | ALogp: | 3.4 |
HBD: | 0 | HBA: | 1 |
Rotatable Bonds: | 6 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 17.1 | Aromatic Rings: | 0 |
Heavy Atoms: | 11 | QED Weighted: | 0.419 |
Caco-2 Permeability: | -4.347 | MDCK Permeability: | 0.00002620 |
Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0.009 |
Human Intestinal Absorption (HIA): | 0.007 | 20% Bioavailability (F20%): | 0.011 |
30% Bioavailability (F30%): | 0.065 |
Blood-Brain-Barrier Penetration (BBB): | 0.994 | Plasma Protein Binding (PPB): | 89.86% |
Volume Distribution (VD): | 0.606 | Fu: | 14.49% |
CYP1A2-inhibitor: | 0.894 | CYP1A2-substrate: | 0.746 |
CYP2C19-inhibitor: | 0.433 | CYP2C19-substrate: | 0.478 |
CYP2C9-inhibitor: | 0.256 | CYP2C9-substrate: | 0.915 |
CYP2D6-inhibitor: | 0.019 | CYP2D6-substrate: | 0.695 |
CYP3A4-inhibitor: | 0.081 | CYP3A4-substrate: | 0.14 |
Clearance (CL): | 9.017 | Half-life (T1/2): | 0.765 |
hERG Blockers: | 0.024 | Human Hepatotoxicity (H-HT): | 0.019 |
Drug-inuced Liver Injury (DILI): | 0.038 | AMES Toxicity: | 0.007 |
Rat Oral Acute Toxicity: | 0.02 | Maximum Recommended Daily Dose: | 0.025 |
Skin Sensitization: | 0.872 | Carcinogencity: | 0.524 |
Eye Corrosion: | 0.991 | Eye Irritation: | 0.987 |
Respiratory Toxicity: | 0.032 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001587 | 0.658 | D0UE9X | 0.338 | ||||
ENC001588 | 0.568 | D0O1TC | 0.329 | ||||
ENC001598 | 0.568 | D0O1PH | 0.315 | ||||
ENC000254 | 0.543 | D0AY9Q | 0.309 | ||||
ENC001683 | 0.529 | D0N3NO | 0.300 | ||||
ENC001599 | 0.525 | D01QLH | 0.300 | ||||
ENC001684 | 0.525 | D0Z5BC | 0.294 | ||||
ENC000454 | 0.500 | D0FD0H | 0.286 | ||||
ENC001601 | 0.488 | D0OR6A | 0.276 | ||||
ENC004479 | 0.488 | D06FEA | 0.269 |